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BACKGROUND: Pathogenesis of severe dengue infection has not been elucidated. Immune complex of pre-existing antibodies and heterotypic 
dengue virus bind to FcγII (cluster of differentiation 
(CD32)) receptor (FcγIIR) on monocyte facilitates entry 
and replication of dengue virus. Aim of this study was to 
evaluate the expression of FcγIIR on monocytes in patients 
infected with dengue and in healthy subjects.
METHODS: This study used a cross-sectional design 
that included patients infected with dengue who were 
hospitalized in Dr. Sardjito General Hospital, Panembahan 
Senopati Hospital, and Sleman Hospital, who met the 
inclusion criteria and selected consecutively. Examinations 
were completed using a lyse, no-wash method of flow 
cytometry.  Computerized statistical analysis was conducted 
and was considered to be significant if p<0.05.
RESULTS: Sixty-five study subjects were divided into 
healthy subjects (24 subjects) and patients with dengue 
infection (41 subjects). There were no significant differences 
in hemoglobin (Hb) and hematocrit (Hct) values between 
the groups, but differences were found in the number of 
leukocytes, absolute number of monocytes and platelet 
count (p<0.001, 0.002 and <0.001, respectively). The mean 
expression of FcγIIR monocytes in patients with dengue 
infection (208.77±32.06 median fluorescent intensity 
(MFI)) and the healthy subjects (124.03±47.76 MFI) with 
p<0.0001.
CONCLUSION: The mean expression of FcγIIR 
monocytes in patients with dengue infection was higher 
than in healthy subjects.
KEywORDS: dengue infection,  FcγII (CD32) receptor 
monocyte, flow cytometry
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Abstract
Introduction
Dengue is an arbovirus that causes infection with any one of 
four related dengue viral serotypes. It is currently the most 
important mosquito-borne viral pathogen affecting humans, 
and it is emerging as a major threat to global health.(1) The 
best estimates available indicate that some 3 billion people 
live in parts of the world where they are at risk for infection 
and that approximately 40 million symptomatic episodes 
and approximately 20,000 deaths occur each year as a 
result of dengue. Currently, neither vaccines nor specific 
therapies are available for this disease, although both areas 
are currently the focus of intense research efforts. With 
expert supportive care, mortality rates have been reduced 
to very low levels, down to less than 1% in many centres of 
excellence for those with severe infections.(2) From 1968 
until 2009, the World Health Organization (WHO) declared 
that Indonesia was the country with the highest rate of 
dengue haemorhagic fever (DHF) in Southeast Asia.(3)
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 Dengue virus (DENV) has four serotypes: dengue 
(DEN)-1, DEN-2, DEN-3 and DEN-4, which target the liver, 
spleen, kidneys, lungs and bone marrow.(4) After being 
bitten by an infected mosquito, DENV enters the body and 
replicates within the mononuclear phagocytic cells (such as 
macrophages/monocytes). The incubation period of DENV 
infection is 7-10 days. The viraemic phase is followed by 
fever at which time the patient becomes infectious. This 
stage can be followed by a convalescent phase or progress 
to the plasma leakage phase that may cause DHF/dengue 
shock syndrome (DSS), that without proper treatment can 
be fatal.(1,5)
 One of the central hypotheses proposed three decades 
ago for the pathogenesis of DHF/DSS was antibody-
dependent enhancement. Pre-existing antibodies to one 
serotype form immune complexes with heterotypic 
serotypes. These immune complexes bind to the FcγII 
(cluster of differentiation (CD)32)  receptor (FcγIIR) on 
monocytes/macrophages that facilitates the entry, replication 
and spread of DENV, increasing the disease severity.(4)
 Dengue infection is divided into four grades of 
severity according to the WHO 2011 criteria. The presence 
of thrombocytopenia (<100,000 cells/mm3) along with 
haemoconcentration (increased hematocrit (Hct) ≥20%) 
differentiates DHF from grades I and II of dengue fever 
(platelets <150,000 cells/mm3 and increased Hct 5-10%), 
while circulatory failure is considered DHF grade III and 
severe shock indicates grade IV or DSS.(6)
 Monocytes and macrophages have long been suspected 
of being the primary target cells of DENV infection. A 
study by Kou, et al., stated that the FcγIIR expressed by 
monocytes plays an important role in the initial steps of 
immune enhancement in patients infected with DENV.
(7,8) Fcγ receptors are immunoglobulin (Ig) receptors for 
IgG that provide the essential network for cellular effector 
mechanisms and humoral immunity, as well as playing 
an important role in immune function. FcγIIR is an IgG 
receptor  that  binds  the  IgG1  subtype-4  with  low  affinity 
and is involved in a number of immune responses including: 
cytotoxicity mediated by antibody-dependent cells; 
clearance of immune complexes; release of inflammatory 
mediators; and regulation of the formation of antibodies.
(9,10) 
 Single point mutations at the gene position 131 
(arginine (R131) or histidine (H131)) encoded by 
FcγIIAR appear to bind IgG subclasses. The FcγIIA-R/
R131 genotype receptor binds IgG1/3 and the FcγIIA-H/
H131 genotype receptor binds IgG2 efficiently. Based on 
this finding, FcγIIAR polymorphisms may alter FcγIIAR 
Methods
This was an observational analytical cross sectional study 
that was conducted in the Pediatric Department of Dr. 
Sardjito Hospital, Yogyakarta, Panembahan Senopati 
Hospital, Bantul, Sleman Hospital, Sleman, Clinical 
Laboratory Installation of Dr. Sardjito Hospital, Yogyakarta 
and the Faculty of Medicine at Universitas Gadjah Mada, 
Yogyakarta from September 2012 to January 2013. The 
inclusion criteria were patients with dengue infection 
included fever (body temperature ≥38°C) for less than 
five days, and the IgM/IgG dengue/nonstructural protein 
1 (NS1)/polymerase chain reaction (PCR) were positive, 
whereas  the  exclusion criteria were if the sampling was 
not feasible; if the data were incomplete; and if there were 
co-infection with other infectious diseases obtained  by 
anamnesis,  communication  with  clinicians and medical 
records. The inclusion criteria for the control group  was 
a  normal  complete blood  count  (CBC)  result,  and  the 
exclusion  criteria  was  a  history  of  rheumatoid  arthritis. 
 This study used ethylene diamine tetra acetate 
(EDTA) blood and FcγIIR expression was determined in 24 
hours after sampling because sample stability only 48 hours. 
Expression of monocytes with FcγIIR in whole blood was 
determined using monoclonal antibody CD32 fluorescein 
isothiocyanate (FITC) (Cat No. #552883), CD14 PE (Cat 
No. #562691) and CD45 PerCP (Cat No. #347464) with a 
BD FACS Calibur flow cytometry (BD Biosciences,  San 
Jose, CA, USA) and Cell-Quest software (BD Biosciences). 
The calibration test of the flowcytometer was carried out 
prior to the examination of the sample material by using 
CaliBRITE beads FACS Comp (BD Bioscience). Coefficient 
of variance of intra-assay precision on the expression of 
FcγIIR monocyte was 3.41%. 
 The collected data were checked for completeness 
and accuracy, then coded and tabulated and inserted 
into the computer. The subject characteristic data were 
presented descriptively in the form of mean and standard 
intersection  for continuous data, while the categorical data 
functions and may be associated with the variability of 
the immune response associated with the pathogenesis of 
dengue.(11) Earlier study showed that FcγIIR expression 
higher in secondary infection than primer.(12)
 Nowadays, there is no data about the level of FcγIIR 
expression in healthy individual. The objective of this study 
was to evaluate the expression of FcγIIR monocytes in 
patients with DENV infection and in healthy subjects.
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were presented in the form of frequency and proportion. A 
mean test and proportion test between the characteristics of 
research subjects was performed.
 Statistical analyses were performed using SPSS v.17.0 
(SPSS Inc, Chicago, Illinois, USA). Continuous data were 
summarized using means for normally distributed data 
and median for abnormally distributed data. Ordinal and 
categorical data were summarized with ratios or proportions. 
Between-group differences were assessed using the Mann-
Whitney test or independent T-test depend on normality. 
Statistical significance was considered if p<0.05.
 This study was approved by Faculty of Medicine 
Universitas Gadjah Mada Ethical Commission Board with 
certificate number KE/FK/256/EC.
Results
 Sixty-five subjects were included in this study, and 
among these 41 patients had dengue infection and 24 
were healthy subjects. In the healthy subjects group, 11 
participants (45.8%) were ≤ 15 years old and 13 participants 
(54.2%) were > 15 years; 12 participants (50%) were male 
and 12 participants (50%) were female. Among  the patients 
in the dengue infection group, 18 participants (41.9%) 
were ≤15 years old were 23 participants (53.3%) were > 15 
years old, also 22 participants (53.7%) were male and 19 
participants (46.3%) were female (Table 1).
Healthy Subjects n (%) Patient with Dengue Infection n (%)
 ≤15; x ± SD 8.4 ± 4.8 11 (45.8) 8.7 ± 4.3 18 (41.9)
 >15; median (min-max) 34 (19-50) 13 (54.2) 22 (16-54) 23 (53.3)
Male - 12 (50) - 22 (53.7)
 Female - 12 (50) - 19 (46.3)
RSUP Dr. Sardjito 23 (56.10)
RSUD P. Senopati 8 (19.51)







The day of fever
Table 1. Study subjects’ demographic and clinical data.
x: mean; SD: standard deviation; min: minimum; max: maximum.
 CBC  test  showed  that  there  is  no  significant 
differences in hemoglobin (Hb) and Hct values, but found 
significant differences in the numbers of leukocytes, 
the absolute number of monocytes, and platelet counts 
(p<0.001, 0.002 and <0.001, respectively) (Table 2). 
There was a significant difference in FcγIIR expression 
on monocytes between healthy subjects and patients with 
dengue infection, p<0.0001 (Table 3).
 There were no cases of hematemesis/melena or 
shock in the patients in the dengue infection group. There 
was a significant difference of FcγIIR between groups in 
hepatomegaly vs. non-hepatomegaly and ascites vs. non-
ascites, p=0.005 and 0.031, respectively (Table 4).
 Of the forty-one patients with dengue infection, 26 
people were diagnosed with dengue fever and 15 with DHF. 
There was no significant difference between the groups in 
the mean FcγIIR expression of the monocytes, Hb, number 
of leukocytes, the absolute number of monocytes and the 
day of fever. However, there was a significant difference in 
the increased value of the Hct and platelet counts (p=0.004 
and 0.004, respectively) (Table 5).
 There was no significant difference  in the expression 
of FcγIIR on monocytes by age group and gender, but a 
significant differences  in the day of fever (p=0.005) between 
the degue fever and DHF groups (Table 6). The mean of 
monocyte’s FcγIIR (CD32) expression was significantly 
different between days 3 and 4 of fever on post-hoc analysis 
(p=0.001).
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Table 2. Haematological characteristics.
Independent sample T-test/*Mann-Whitney, significant if p< 0.05. abs: absolute






Hb (g/dL); x ± SD 13.20 ± 1.50 13.74 ± 2.03 0.235
Hct (%); x ± SD 39.81 ± 4.02 39.98 ± 5.58 0.886
∑ leukocyte (103/µL); median (min-max) 7.91 (4.30-10.47) 3.57 (1.10-10.50) <0.001*
∑ abs. Monocyte (103/µL); median (min-max) 0.52 (0.15-1.87) 0.24 (0.07-0.86) 0.002*
∑ platelet (103/µL); x ± SD 263.58 ± 47.76 89.78 ± 48.41 <0.001
Monocyte’s FcγIIR 
(CD32) Expression
Mean ± SD (MFI)
Healthy subjects 24 (36.92) 124.03 ± 47.76
Patients with dengue infection 41 (63.08) 208.77 ± 32.06
Variable n (%) p- value
<0.0001
Independent T-test, significant if p<0.05.
Discussion
Ribonucleic acid (RNA) of DENV has been isolated 
from the bone marrow in patients infected with DENV, 
indicating that the bone marrow and hematopoietic system 
were also the target of DENV. In addition, DENV was 
also recently isolated from polymorphonuclear neutrophil 
(PMN), monocytes/macrophages and dendritic cells.(13) 
Leukopenia and monocytopoenia in this study was similar 
with the study that that conducted by Kalayanarooj, et al., 
in Bangkok in children with a fever less than 72 hours, for 
whom neutropenia and monocytopoenia signified dengue 
infection vs. other fever illness.(14) Similar results were 
also obtained in a study from the Philippines in which 
215 dengue patients had routine haematology checked on 
the fourth or fifth day of fever, which found 136 patients 
(63.3%) had leucopoenia.(15)
 Funahara, et al., proved that the DENV antigen can 
affect platelets directly without going through the immune 
responses.(16) A recent study conducted by Ghosh, et 
al., showed that DENV can directly interact and activate 
platelets. RNA and DENV particles had also been detected 
in platelets in patients infected with DENV, indicating that 
DENV was able to replicate in platelets by an unknown 
mechanism.(13)
 Hepatomegaly was more frequently found in patients 
with DHF compared to dengue fever. Hepatic dysfunction 
could occur due to the direct effects of the infection or 
because of an immune response.(17) Interaction between 
the immune response and the impact on the integrity and 
function of the endothelial cells caused increased vascular 
permeability and plasma leakage.(18) Monocytes produced 
cytokines that caused the activation of endothelial cells 
that expressed adhesion molecules such as vascular cell 
adhesion molecule (VCAM)-1 and intercellular adhesion 
molecule (ICAM)-1.(19) Pleural effusion and ascites were 
suspected to have occurred because of the increased vascular 
permeability.(20)
 The pilot study was conducted by Durbin, et al., 
during August 2005 - February 2006 in Nicaragua in 
children with DENV infection by using peripheral blood 
mononuclear cell (PBMC) obtained from most of the cells 
containing the dengue antigen expressed phenotype typical 
of activated monocytes, even at primary dengue infection. 
FcγIIR expression on monocytes in patients with DHF vs. 
dengue fever were significantly different, p=0.01.(21) In 
contrast with this study’s results that showed no significant 
differences in FcγIIR expression on monocytes between 
dengue fever vs. DHF groups, the expression of FcγIIR 
on monocytes in dengue patients was likely influenced by 
the patterns of viraemia and the kinetics of the immune 
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Table 4. Comparison of the FcγII (CD32) receptor expression on monocytes of 
patients with dengue infection based on clinical symptoms of dengue infection.
Monocyte FcγIIR 
(CD32) Expression 
Mean ± SD (MFI)
Yes 0 (0) -
No 41 (100) 208.77 ± 32.06
Yes 0 (0) -
No 41 (100) 208.77 ± 32.06
Yes 8 (19.51) 187.92 ± 18.39
No 33 (80.49) 215.55 ± 33.53
Yes 5 (8.20) 191.54 ± 31.60
No 36 (87.80) 212.74 ± 32.64
Yes 3 (7.32) 178.54 ± 14.92
No 38 (92.68) 212.65 ± 32.71
Yes 0 (0) -













n (%) p -value
-
Independent T-test, significant if p<0.05.
DF (n=26) DHF (n=15)
FcγIIR(CD32) (MFI); x ± SD 217.05 ± 33.38 198.22 ± 29.33 0.069
Mean Hb (g/dL); x ± SD 13.41 ± 1.74 14.30 ± 2.42 0.228
Hct (%); x ± SD 39.27 ± 4.85 41.21 ± 6.66 0.335
Δ Hct (%); x ± SD 4.35 ± 1.81 6.87 ± 2.47 0.002
Increase Hct (%); x ± SD 12.22 ± 5.56 19.78 ± 8.06 0.004
Leukocytes count (103/µL); median (min-max) 3.28 (1.10-10.50) 4.10 (1.20-7.83) 0.317*
∑ abs. monocytes (103/µL); median (min-max) 0.33 (0.07-0.86) 0.22 (0.08-0.85) 0.192*
Platelet count (103/µL); x ± SD 105.77 ± 45.44 62.07 ± 41.3 0.004
The day of fever; median (min-max) 3 (1-4) 4 (3-4) 0.053*
Variable
Patient with dengue infection
p- value
Independent T-test/*Mann-Whitney, significance if p<0.05.
Table 5. FcγII (CD32) receptor expression on monocytes, haematology variables and the day of 
fever based on the degree of severity.
response to dengue infection caused this study used subjects 
with various day of fever. Other study confirm that FcγIIR 
expression on monocytes was not related to clinical severity. 
 Dengue infection is the result of a multifactorial 
interaction between agents, the host, and the environment. 
On the one hand, the immune response can be beneficial, 
but it may also be detrimental, which prompted the interest 
of the authors interested in understanding the involvement 
of genetic factors in these infections, namely genetic 
susceptibility.(16) Several studies have confirmed that 
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certain genetic polymorphisms may provide protection 
to individuals who suffer from DHF preventing DSS. 
Loke, et al., found that the variant homozygous arginine 
at position 131 of the FcγRIIA genes have low capacity 
for opsonization IgG2 antibodies that provide protection 
for the DHF.(9) Furthermore, the interaction between the 
complex and the virus-antibody FcγRIIA (DENV/IgG1/
IgG3) was associated with the formation of an efficient 
phagolysosome to eliminate immune complexes and control 
the spread of virus.(11) antibody-dependent enhancement 
(ADE) hypothesis states that non neutralizing antibodies in 
secondary infection may enhances dengue infection. Higher 
FcγIIR expression in dengue patients indicate secondary 
than primary infection.(12)   
Table 6. Monocyte FcγII (CD32) receptor expression in patients with 
dengue infection group based on age, gender, and the day of fever.
Monocyte’s FcγIIR 
(CD32) expression 
Mean ± SD (MFI)
≤15 th 18 (43.9%) 207.02 ± 34.75
 >15 th 23 (56.1%) 212.62 ± 31.92
Male 22 (53.7%) 202.73 ± 34.22
Perempuan 19 (46.3%) 218.76 ± 29.87
1 2 (4.9%) 203.43 ± 52.96
2 0 (0%) -
3 22 (53.9%) 224.97 ± 29.24




The day of fever
Variable n (%) p- value
0.599
0.117
Independent T-test /#one way ANOVA, significant if p<0.05.
Conclusion
The mean expression of FcγIIR (CD32) on monocytes in 
patients with dengue infection was higher than in healthy 
subjects. FcγIIR expression was not significantly different 
between dengue fever and DHF.
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